Statistics

Total Visits

Views
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a biomarker for the effect of PTK787/ZK 222584 as second-line mono-therapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC). 188

Total Visits per Month

November 2015 December 2015 January 2016 February 2016 March 2016 April 2016 May 2016
Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) as a biomarker for the effect of PTK787/ZK 222584 as second-line mono-therapy in patients with stage IIIB or stage IV non-small-cell lung cancer (NSCLC). 0 6 4 1 1 4 3

File Downloads

Views
dce-mri abstract.pdf 21

Top Country Views

Views
United States 61
Canada 16
China 9
Russia 9
United Kingdom 8
Germany 4
France 4
Netherlands 4
Italy 3
South Korea 3

Top City Views

Views
Miami Beach 23
Toronto 12
Santa Clara 6
Zhengzhou 6
Kansas City 5
Munich 3
Beijing 2
Busto Arsizio 2
Lethbridge 2
Menlo Park 2